Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Dingdang Health (09886.HK) repurchased 868,500 shares for HKD 754,000 on October 26.
26/10/2026
Zhitong Finance APP News, Dingdang Health (09886.HK) announced that on October 26, 2026, the company spent HK$754,000 to repurchase 868,500 shares.
Latest
3 m ago
Jiww High-Tech (300631.SZ) released its first three quarters performance, with net profit attributable to the parent company of 64.1895 million yuan, a year-on-year increase of 32.25%.
4 m ago
CSPC Pharmaceutical Group (01093): The Phase III clinical study results of anitumab combined with docetaxel for injection (albumin-bound) (HB1801) for first-line treatment of HER2-positive advanced breast cancer were presented as a preferred oral presentation at the 2026 ESMO Annual Meeting.
4 m ago
Corning Jereh Pharmaceutical-B (09966) presented the latest research progress of JSKN003 at the 2026 ESMO Congress.
5 m ago
Linklogis Technology-W (09959.HK) Achieves Significant Revenue and Income Growth in the First Three Quarters, Continues to Advance AI Strategic Transformation and Global Layout
8 m ago
Smoore International (06969.HK) repurchased 1.114 million shares at a cost of approximately HK$9.4026 million on October 26.
See all latest